Bank of Montreal’s Paratek Pharmaceuticals, Inc. PRTK Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTK
OFM
RSCM
BC
GAI
A
ACM
GIM
Bank of Montreal's PRTK Position: Q2 2021 in Review
Bank of Montreal sold out of Paratek Pharmaceuticals, Inc. (PRTK) in Q2 2021, closing a stake of 2,692 shares — an estimated $18K sold.
Bank of Montreal first reported a position in PRTK in Q1 2017 and held it in 17 quarters. The position peaked at $136K in Q1 2018. 116 funds tracked by Wall St. Rank hold PRTK as of Q2 2021.
- Bank of Montreal reported no remaining Paratek Pharmaceuticals, Inc. position as of Q2 2021 after selling out during the quarter.
- Bank of Montreal sold 2,692 Paratek Pharmaceuticals, Inc. shares in Q2 2021, an estimated $18K.
- Bank of Montreal first reported a position in Paratek Pharmaceuticals, Inc. in Q1 2017 and held it in 17 quarters.
- Bank of Montreal's Paratek Pharmaceuticals, Inc. position peaked at $136K in Q1 2018.
- 116 funds tracked by Wall St. Rank held Paratek Pharmaceuticals, Inc. as of Q2 2021.
Based on Bank of Montreal's 13F filing for Q2 2021, filed 12 Aug 2021.